메뉴 건너뛰기




Volumn 57, Issue 4, 2011, Pages 684-687

Systemic mastocytosis in a child with t(8;21) acute myeloid leukemia

Author keywords

AML; Molecular diagnosis and therapy; Pediatric hematology oncology; Systemic mastocytosis

Indexed keywords

CLOFARABINE; CYTARABINE; DAUNORUBICIN; ETOPOSIDE; MITOXANTRONE;

EID: 79961181551     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.23026     Document Type: Article
Times cited : (16)

References (10)
  • 1
    • 69849091836 scopus 로고    scopus 로고
    • Pediatric-onset mastocytosis: a long term clinical follow-up and correlation with bone marrow histopathology
    • Uzzaman A, Maric I, Noel P, et al. Pediatric-onset mastocytosis: a long term clinical follow-up and correlation with bone marrow histopathology. Pediatr Blood Cancer 2009; 53: 629-634.
    • (2009) Pediatr Blood Cancer , vol.53 , pp. 629-634
    • Uzzaman, A.1    Maric, I.2    Noel, P.3
  • 2
    • 49349090384 scopus 로고    scopus 로고
    • Mastocytosis in children: a protocol for management
    • Heide R, Beishuizen A, De Groot H, et al. Mastocytosis in children: a protocol for management. Pediatr Dermatol 2008; 25: 493-500.
    • (2008) Pediatr Dermatol , vol.25 , pp. 493-500
    • Heide, R.1    Beishuizen, A.2    De Groot, H.3
  • 3
    • 0032188805 scopus 로고    scopus 로고
    • The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1612 Patients Entered Into the MRC AML 10 Trial
    • Grimwade D, Walker H, Oliver F, et al. The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1612 Patients Entered Into the MRC AML 10 Trial. Blood 1998; 92: 2322-2333.
    • (1998) Blood , vol.92 , pp. 2322-2333
    • Grimwade, D.1    Walker, H.2    Oliver, F.3
  • 4
    • 33845193026 scopus 로고    scopus 로고
    • Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic clone
    • Pullarkat V, Bedell V, Kim Y, et al. Neoplastic mast cells in systemic mastocytosis associated with t(8;21) acute myeloid leukemia are derived from the leukemic clone. Leuk Res 2007; 31: 261-265.
    • (2007) Leuk Res , vol.31 , pp. 261-265
    • Pullarkat, V.1    Bedell, V.2    Kim, Y.3
  • 5
    • 0037405219 scopus 로고    scopus 로고
    • Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: Analysis of clinicopathologic features and activating c-kit mutations
    • Pullarkat V, Bueso-Ramos C, Lai R, et al. Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: Analysis of clinicopathologic features and activating c-kit mutations. Am J Hematol 2003; 73: 12-17.
    • (2003) Am J Hematol , vol.73 , pp. 12-17
    • Pullarkat, V.1    Bueso-Ramos, C.2    Lai, R.3
  • 6
    • 76749152847 scopus 로고    scopus 로고
    • Current approaches to the diagnosis and treatment of systemic mastocytosis
    • Bains SN, Hsieh FH. Current approaches to the diagnosis and treatment of systemic mastocytosis. Ann Allergy Asthma Immunol 2010; 104: 1-10.
    • (2010) Ann Allergy Asthma Immunol , vol.104 , pp. 1-10
    • Bains, S.N.1    Hsieh, F.H.2
  • 7
    • 79959362120 scopus 로고    scopus 로고
    • Systemic mastocytosis associated with t(8;21)(q22;q22) acute myeloid leukemia
    • Pullarkat ST, Pullarkat V, Kroft SH, et al. Systemic mastocytosis associated with t(8;21)(q22;q22) acute myeloid leukemia. J Hematopathol 2009; 2: 27-33.
    • (2009) J Hematopathol , vol.2 , pp. 27-33
    • Pullarkat, S.T.1    Pullarkat, V.2    Kroft, S.H.3
  • 8
    • 77950612017 scopus 로고    scopus 로고
    • Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML
    • Pollard JA, Alonzo TA, Gerbing RB, et al. Prevalence and prognostic significance of KIT mutations in pediatric patients with core binding factor AML enrolled on serial pediatric cooperative trials for de novo AML. Blood 2010; 115: 2372-2379.
    • (2010) Blood , vol.115 , pp. 2372-2379
    • Pollard, J.A.1    Alonzo, T.A.2    Gerbing, R.B.3
  • 9
    • 33344471932 scopus 로고    scopus 로고
    • KIT mutations, and not FLT3 internal tandem duplication, are strongly associated with a poor prognosis in pediatric acute myeloid leukemia with t(8;21): a study of the Japanese Childhood AML Cooperative Study Group
    • Shimada A, Taki T, Tabuchi K, et al. KIT mutations, and not FLT3 internal tandem duplication, are strongly associated with a poor prognosis in pediatric acute myeloid leukemia with t(8;21): a study of the Japanese Childhood AML Cooperative Study Group. Blood 2006; 107: 1806-1809.
    • (2006) Blood , vol.107 , pp. 1806-1809
    • Shimada, A.1    Taki, T.2    Tabuchi, K.3
  • 10
    • 0041656424 scopus 로고    scopus 로고
    • Imatinib for systemic mast-cell disease
    • Pardanani A, Elliott M, Reeder T, et al. Imatinib for systemic mast-cell disease. Lancet 2003; 362: 535-536.
    • (2003) Lancet , vol.362 , pp. 535-536
    • Pardanani, A.1    Elliott, M.2    Reeder, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.